Advanced search
Publication Cover
Leukemia & Lymphoma Volume 6, 1991 - Issue 1
Submit an article Journal homepage
17
Views
0
CrossRef citations to date
0
Altmetric
Original Article

High Dose, Short Duration Combination Chemotherapy (MEGA III) for Patients with High Grade Poor Prognosis Non-Hodgkin's Lymphoma—A Phase I/II Study

S. H. Lim Departments of Haematology, Addenbrooke's Hospital, Hills Road, Cambridge
,
E. M. Richards Departments of Haematology, Addenbrooke's Hospital, Hills Road, Cambridge
,
J. Z. Wimperis Departments of Haematology, Addenbrooke's Hospital, Hills Road, Cambridge
,
J. Braithwaite James Paget Hospital, Gorleston, Norfolk, UK
&
R. E. Marcus Departments of Haematology, Addenbrooke's Hospital, Hills Road, Cambridge
Pages 53-59 | Received 20 May 1991, Published online: 01 Jul 2009

References

  • Coltman C. A., Dahlberg S., Jones S. E. CHOP is curative in thirty percent of patients with large cell lymphoma: A twelve year Southwest Oncology Group follow up. Advances in Cancer Chemotherapy, A. T. Skarin. Park Row, New York 1986; 71–78
  • Armitage J. O., Fyfe M. E., Lewis J. Long term remission durability and functional status of patients treated for diffuse histiocytic lymphoma with the CHOP regimen. J. Clin. Oncol 1984; 2: 898–902
  • Gams R. A., Rainey M., Danay M. Phase III study of BCOP versus CHOP in unfavourable categories of malignant lymphoma: A Southeastern Cancer Study Group trial. J. Clin. Oncol 1985; 3: 1188–1195
  • O'Connell M. J., Harrington D. P., Earle J. D. Prospectively randomised clinical trials of three intensive chemotherapy regimens for the treatment of advanced unfavourable histology non-Hodgkin's lymphoma. J. Clin. Oncol 1987; 35: 1329–1339
  • McElvey E. M., Gottlieb J. A., Wilson H. E. Hydroxydaunomycin combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484–1493
  • Canellos G. P., Skarin A. T., Klatt M. M. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large cell lymphoma. Semin. Hematol 1987; 24: 2–7
  • Klimo P., Connors J. M. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann. Intern. Med 1985; 102: 596–602
  • Goldie J. H., Coldman A. J. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rates. Cancer Treat. Rep 1979; 63: 1727–1733
  • The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classification of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
  • Slater D. E., Mertelsmann R., Koziner B. Lymphoblastic lymphoma in adults. J. Clin. Oncol 1986; 4: 57–67
  • Nathwani B. N., Dixon D. O., Jones S. E. The clinical significance of the morphological subdivision of diffuse `histiocytic' lymphoma. A study of 162 patients treated by the Southwest Oncology Group. Blood 1982; 60: 1068–1074
  • Simon R., Durrleman S., Hoppe R. T. The non-Hodgkin's lymphoma pathologic classification project. Long-term follow-up of 1153 patients with non-Hodgkin's lymphoma. Ann. Intern. Med 1988; 109: 939–945
  • Lamb R., Bunn P. A., Jr. T-cell lymphoreticular malignancies in adults. The non-Hodgkin's lymphomas, I. Magrath, T. Edward Arnold, London 1990; 330–351
  • Coiffier B., Lepage E. Prognosis of aggressive lymphomas: A study of five prognostic models with patients included in the LNH-84 regimen. Blood 1989; 74: 558–564
  • Shipp M. A., Harrington D. P., Klatt M. M. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann. Intern. Med 1986; 104: 757–765
  • Orr S. T., Aisner J. Performance status assessment among oncology patients: A review. Cancer Treat. Rep 1986; 70: 1423–1435
  • McMaster M. L., Greer J. P., Greco F. A., Johnson D. H., Wolff S. N., Hainsworth J. D. High intensity, brief duration chemotherapy improves outcome in patients with very poor prognosis non-Hodgkin's lymphoma (NHL). Proc. Am. Soc. Clin. Oncol 1990; 988
  • Baglin T. P., Marcus R. E., Joysey V. Graft versus host disease following blood product transfusion or solid organ transplantation. Br. J. Haematol 1991; 77: 22, (Suppl. 1.)
  • Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207–214
  • Laurence J., Coleman M., Allen S. L. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. Ann. Intern. Med 1982; 97: 190–195
  • Longo D., De Vita VT, Duffay P. Randomised trial of ProMACE-MOPP (Day (D)1, D8) (PM) vs ProMACE-CytaBOM (PC) in stage II-IV aggressive non-Hodgkin's lymphoma. Proc. Am. Soc. Clin. Oncol 1987; 6: 206
  • Fisher R. I., De Vita V. T., Hubbard S. M. Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy. Ann. Intern. Med 1983; 98: 304–309
  • Philip T., Armitage J. O., Spitzer G. High dose therapy and ABMT after failure of conventional chemotherapy in one hundred adults with intermediate or high grade non-Hodgkin's lymphoma. N. Engl. J. Med 1987; 316: 1493–1498
  • Wade J. C., Schimpff S. C., Newman K. A., Wiernick P. H. Staphylococcus epidermidis: An increasing cause of infection in patients with granulopenia. Ann. Intern. Med 1982; 97: 503–508

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.